Dyadic International, Inc. is a global biotechnology platform company with operations in the United States. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It has licensed this technology to third parties, such as Abengoa Bioenergy, BASF,Codexis and others, for industrial applications. This technology is based on the Thermothelomyces heterothallica fungus, namely C1. The C1-cell protein production platform is a robust and versatile thermophilic filamentous fungal expression system for the development and production of biologic products, including enzymes and other proteins for human and animal health. The Company also developed the Dapibus thermophilic filamentous fungal based microbial protein production platform to enable the rapid development and large-scale manufacture of proteins, metabolites and other biologic products for use in non-pharmaceutical applications, such as food, nutrition and wellness.
More about the company